Skip to main content
. Author manuscript; available in PMC: 2014 Jan 7.
Published in final edited form as: Mol Pharmacol. 1996 Oct;50(4):728–735.

TABLE 3. Activity of NADPH:cytochrome P-450 reductase, NADH:cytochrome b5 reductase, and xanthine dehydrogenase/oxidase in parental CHO cells and transfectants expressing human NQO1.

Values are mean ± standard deviations of at least four independent determinations. NADPH:cytochrome P-450 reductase and NADH:cytochrome b5 reductase were measured in whole-cell lysates by monitoring the reduction of cytochrome c in the presence of NADPH or NADH, respectively. Xanthine dehydrogenase/oxidase activity was measured by monitoring the conversion of xanthine to uric acid in the presence and absence of NAD+. Assays were done on whole-cell lysates for NADPH:cytochrome P-450 reductase and NADH:cytochrome b5 reductase and the supernatant after centrifugation at 15,000 × g for xanthine dehydrogenase/oxidase. Lysate from ~106 cells was used for each assay, and total protein was determined in the samples using the BCA total protein assay.

Cell line P-450Ra b5Rb XDH/XOc
CHO 3.3 ± 1.2 33.7 ± 12.0 5.7 ± 2.3
DTD1 5.0 ± 2.1
DTD812 4.5 ± 1.1 47.9 ± 4.0 3.4 ± 1.4
DTD815 9.6 ± 4.0 55.4 ± 9.0 1.3 ± 1.2
DTD818 7.4 ± 1.7 51.0 ± 6.2 4.9 ± 1.0
a

NADPH:cytochrome P-450 reductase activity is expressed in nmol of cytochrome c reduced/min/mg of protein.

b

NADH:cytochrome b5 reductase activity is expressed in nmol of cytochrome c reduced/min/mg of protein.

c

Xanthine dehydrogenase/oxidase activity is expressed in nmol of uric acid formed/min/mg of protein. All XDH/XO activity was NAD+ dependent.